platinum has been researched along with Cancer, Second Primary in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arakawa, Y; Hasegawa, D; Hata, K; Imamura, T; Inoue, A; Ishimaru, S; Ishiwata, K; Ito, S; Kato, M; Kawai, T; Kiyokawa, N; Kiyotani, C; Koh, K; Manabe, A; Matsumoto, K; Nakabayashi, K; Niwa, A; Ogata-Kawata, H; Ogawa, S; Okamura, K; Osumi, T; Sakamoto, M; Sato-Otsubo, A; Shioda, Y; Shirai, R; Takagi, M; Terashima, K; Tomizawa, D; Tsujimoto, SI; Yang, JJ; Yang, W; Yoshida, K; Yoshida, M; Yoshioka, T; Yuza, Y | 1 |
| Dang, C; Li, K; Ma, R; Mo, C; Yin, J; Yuan, D; Zhang, Y; Zhu, K | 1 |
| Aarts, MJB; de Jong, IJ; de Wit, R; Gietema, JA; Groenewegen, G; Groot, HJ; Horenblas, S; Hulshof, MCCM; Jóźwiak, K; Lubberts, S; Meijer, OWM; Poortmans, PM; Schaapveld, M; Smilde, TJ; van den Belt-Dusebout, AW; van den Berg, HA; van Leeuwen, FE; Vanneste, BGL; Witjes, JA | 1 |
| Cortes-Bullich, A; Gonzalez-Perez, A; Lopez-Bigas, N; Muiños, F; Pich, O; Pratcorona, M | 1 |
| Müller, AC; Utz, D | 1 |
| Abedin, S; Guru Murthy, GS | 1 |
| Cai, R; Fan, Y; Hong, R; Li, Q; Ma, F; Shi, X; Wang, J; Xu, B; Yuan, P; Zhang, P | 1 |
| Foretová, L; Fridrichová, P; Laco, J; Melichar, B; Papajík, T; Simkovič, M | 1 |
| Gerl, A; Schierl, R | 1 |
| Brasnu, D; Hans, S; Laccourreye, H; Laccourreye, O; Ménard, M; Veivers, D | 1 |
1 review(s) available for platinum and Cancer, Second Primary
| Article | Year |
|---|---|
Myeloid malignancies after treatment for solid tumours.
Topics: Chemotherapy, Adjuvant; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Humans; Male; Myeloproliferative Disorders; Neoplasms, Second Primary; Platinum; Risk Factors; Topoisomerase II Inhibitors | 2019 |
1 trial(s) available for platinum and Cancer, Second Primary
| Article | Year |
|---|---|
[Comparison of the effectiveness of platinum-based chemotherapy versus non-platinum-based chemotherapy for triple-negative breast cancer with metastases confined to the lungs].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Humans; Lung Neoplasms; Neoplasms, Second Primary; Platinum; Triple Negative Breast Neoplasms | 2014 |
8 other study(ies) available for platinum and Cancer, Second Primary
| Article | Year |
|---|---|
Prevalence of pathogenic variants in cancer-predisposing genes in second cancer after childhood solid cancers.
Topics: Brain Neoplasms; Child; DEAD-box RNA Helicases; Genetic Predisposition to Disease; Germ-Line Mutation; Humans; Leukemia; Neoplasms, Second Primary; Platinum; Prevalence; Ribonuclease III | 2023 |
Factors affecting the ORR after neoadjuvant therapy of TP regimen combined with PD-1 inhibitors for esophageal cancer.
Topics: Carcinoembryonic Antigen; Esophageal Neoplasms; Humans; Immune Checkpoint Inhibitors; Neoadjuvant Therapy; Neoplasms, Second Primary; Platinum; Programmed Cell Death 1 Receptor; Retrospective Studies | 2023 |
Platinum exposure and cause-specific mortality among patients with testicular cancer.
Topics: Adult; Antineoplastic Agents; Cause of Death; Cisplatin; Cohort Studies; Female; Humans; Male; Middle Aged; Neoplasms, Second Primary; Platinum; Proportional Hazards Models; Risk Factors; Survivorship; Testicular Neoplasms; Young Adult | 2020 |
The evolution of hematopoietic cells under cancer therapy.
Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clonal Evolution; Clone Cells; Cohort Studies; Female; Fluorouracil; Hematopoiesis; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid; Mutagenesis; Mutation; Neoplasms, Second Primary; Platinum; Tumor Suppressor Protein p53 | 2021 |
[Risk of second malignancies after platinum-based chemotherapy of testicular cancer].
Topics: Cisplatin; Humans; Male; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Platinum; Testicular Neoplasms | 2019 |
Therapy-related myeloid neoplasms in epithelial ovarian cancer patients carrying BRCA1 mutation: report of two cases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ovarian Epithelial; Cystadenocarcinoma, Serous; Fatal Outcome; Female; Genes, BRCA1; Heterozygote; Humans; Leukemia, Myeloid, Acute; Middle Aged; Mutation; Neoplasms, Glandular and Epithelial; Neoplasms, Second Primary; Ovarian Neoplasms; Paclitaxel; Platinum | 2012 |
Urinary excretion of platinum in chemotherapy-treated long-term survivors of testicular cancer.
Topics: Adult; Antineoplastic Agents; Cisplatin; Endocrine System Diseases; Follow-Up Studies; Humans; Male; Metabolic Diseases; Neoplasms, Second Primary; Platinum; Testicular Neoplasms | 2000 |
Chemotherapy alone with curative intent in patients with invasive squamous cell carcinoma of the pharyngolarynx classified as T1-T4N0M0 complete clinical responders.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Therapy, Combination; Female; Fluorouracil; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasm Invasiveness; Neoplasms, Second Primary; Pharyngeal Neoplasms; Platinum; Salvage Therapy | 2001 |